Mithra Pharmaceuticals S.A.

    Mithra Pharmaceuticals S.A.

    EEURONEXT:MITRA
    - -
    EUR
    - -
    - -
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    Revenue per Share
    0.48
    0.58
    0.97
    0.66
    0.72
    0.99
    1.58
    2.56
    0.22
    0.52
    1.37
    Basic EPS, GAAP
    -0.02
    -0.05
    -0.15
    -0.32
    -1.13
    -1.07
    -0.34
    -0.7
    -2.25
    -2.69
    -1.22
    Free Cash Flow per Basic Share
    0.02
    -0.01
    -0.14
    -0.95
    -1.27
    -1.44
    -0.18
    -1.65
    -2.35
    -2.26
    -1.68
    Dividend per Share
    - -
    0.02
    0.11
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.07
    0.08
    -0.26
    0.15
    -0.96
    -1.88
    -2.03
    -2.62
    -4.6
    -7.01
    -7.24
    Tangible Book Value per Share
    - -
    0.02
    0.17
    1.32
    0.28
    0.04
    1.74
    1.87
    1.55
    -1.76
    -2.17
    Basic Weighted Avg Shares
    31
    31
    20
    31
    31
    33
    37
    38
    41
    43
    49
    Sales/Revenue/Turnover
    15
    18
    19
    20
    22
    32
    58
    97
    9
    23
    67
    Operating Margin (%)
    1.68
    -3.16
    -15.39
    -69.82
    -160.12
    -80.51
    24.51
    26.99
    -926.67
    -387.67
    -39.17
    Depreciation Expense
    1
    1
    1
    1
    1
    2
    3
    6
    10
    10
    12
    Net Income, GAAP
    -1
    -2
    -3
    -10
    -35
    -35
    -12
    -27
    -92
    -117
    -60
    Effective Tax Rate (%)
    1,240
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -4.25
    -8.64
    -15.52
    -48.06
    -156.16
    -108.56
    -21.36
    -27.52
    -1,019.78
    -515.59
    -88.99
    Working Capital
    - -
    - -
    - -
    75
    30
    22
    107
    44
    168
    4
    15
    LT Debt
    1
    1
    2
    3
    40
    49
    67
    64
    168
    168
    176
    Total Equity
    2
    2
    6
    127
    93
    87
    151
    163
    158
    34
    34
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -68.02
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    231.82%
    -0.1%
    -0.45%
    Free Cash Flow
    243.5%
    160.86%
    -15.81%
    Net Income, GAAP
    100.13%
    54.96%
    -48.99%
    Sales/Revenue/Turnover
    49.05%
    80.44%
    195.56%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    23
    2022
    - -
    - -
    - -
    - -
    67
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    -2.69
    2022
    - -
    - -
    - -
    - -
    -1.22
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business